AT475434T - Hemostatic sprays and compositions - Google Patents

Hemostatic sprays and compositions

Info

Publication number
AT475434T
AT475434T AT05700613T AT05700613T AT475434T AT 475434 T AT475434 T AT 475434T AT 05700613 T AT05700613 T AT 05700613T AT 05700613 T AT05700613 T AT 05700613T AT 475434 T AT475434 T AT 475434T
Authority
AT
Austria
Prior art keywords
hemostatic
sprays
compositions
Prior art date
Application number
AT05700613T
Other languages
German (de)
Inventor
Fisker Lene Moller
Original Assignee
Ferrosan As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US54000504P priority Critical
Priority to US54697204P priority
Application filed by Ferrosan As filed Critical Ferrosan As
Priority to PCT/DK2005/000063 priority patent/WO2005072700A2/en
Publication of AT475434T publication Critical patent/AT475434T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06Ampoules or carpules
    • A61J1/067Flexible ampoules, the contents of which are expelled by squeezing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/363Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/37Factors VIII
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45Transferases (2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/4833Thrombin (3.4.21.5)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/4846Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/57Protease inhibitors from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325Collagen
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D1/00Containers having bodies formed in one piece, e.g. by casting metallic material, by moulding plastics, by blowing vitreous material, by throwing ceramic material, by moulding pulped fibrous material, by deep-drawing operations performed on sheet material
    • B65D1/32Containers adapted to be temporarily deformed by external pressure to expel contents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00Containers or packages with special means for dispensing contents
    • B65D83/06Containers or packages with special means for dispensing contents for dispensing powdered or granular material
AT05700613T 2004-01-30 2005-01-28 Hemostatic sprays and compositions AT475434T (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US54000504P true 2004-01-30 2004-01-30
US54697204P true 2004-02-24 2004-02-24
PCT/DK2005/000063 WO2005072700A2 (en) 2004-01-30 2005-01-28 Haemostatic sprays and compositions

Publications (1)

Publication Number Publication Date
AT475434T true AT475434T (en) 2010-08-15

Family

ID=34830497

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05700613T AT475434T (en) 2004-01-30 2005-01-28 Hemostatic sprays and compositions

Country Status (10)

Country Link
US (1) US7923031B2 (en)
EP (1) EP1713521B1 (en)
JP (1) JP2007519450A (en)
CN (1) CN1921896B (en)
AR (1) AR054637A1 (en)
AT (1) AT475434T (en)
CA (1) CA2554994C (en)
DE (1) DE602005022554D1 (en)
RU (1) RU2377022C9 (en)
WO (1) WO2005072700A2 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7927626B2 (en) 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
KR20070046093A (en) * 2004-07-09 2007-05-02 훼로산 아크티에 셀스카브 Haemostatic composition comprising hyaluronic acid
FR2881651A1 (en) * 2005-02-09 2006-08-11 Urodelia Sa New pharmaceutical and manufacturing this pharmaceutical PROCESS
ES2399138T3 (en) 2006-03-16 2013-03-26 Stellaris Pharmaceuticals Aps Local treatment with factor VII
US20080004431A1 (en) * 2006-06-30 2008-01-03 Warsaw Orthopedic Inc Method of manufacturing an injectable collagen material
JP5569398B2 (en) 2008-02-29 2014-08-13 フェッローサン メディカル ディバイス エー/エス Apparatus for facilitating hemostasis and / or wound healing
DE102008015961A1 (en) 2008-03-20 2009-09-24 Gelita Ag Using gelatin particles in powder coating process
NZ593308A (en) 2008-12-15 2013-05-31 Profibrix Bv Device for topically dispensing a powder including a gasflow generator to agitate an attached powder receptacle
EP2332438A1 (en) * 2009-12-14 2011-06-15 KPSS-Kao Professional Salon Services GmbH Nozzle for applying a powder
CA2801116C (en) 2010-06-01 2019-02-12 Baxter International Inc. Process for making dry and stable hemostatic compositions
CN101857095B (en) * 2010-06-13 2012-04-04 林虎强 Method for lubricating by using graphite powder
MD4163C1 (en) * 2010-12-23 2012-11-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Medicinal preparation in the form of gel for the prevention of postoperative complications
GB201021881D0 (en) 2010-12-23 2011-02-02 Profibrix Bv Powder delivery device
WO2012122044A2 (en) * 2011-03-04 2012-09-13 Orthovita, Inc. Flowable collagen-based hemostat and methods of use
RU2557917C2 (en) * 2011-04-01 2015-07-27 Чжухай Ортус Биотекнолоджи Ко., Лтд Medical absorable haemostatic material for osteal wounds and method for producing
RS54247B1 (en) 2011-04-27 2016-02-29 Biom'up Biomedical haemostatic powder dispenser
CA2830659A1 (en) 2011-04-27 2012-11-01 Biom'up Hemostatic compositions
US8999376B2 (en) * 2012-02-03 2015-04-07 Xcede Technologies, Inc. Tissue patch
JP6394916B2 (en) * 2012-06-12 2018-09-26 フェロサン メディカル デバイシーズ エイ/エス Dry hemostatic composition
US10016527B2 (en) 2012-10-23 2018-07-10 Orthovita, Inc. Materials and methods for repair of cartilage defects
WO2014113589A1 (en) * 2013-01-17 2014-07-24 Merit Medical Systems, Inc. Apparatuses and kits for grinding or cutting surgical foam and methods related thereto
US9474718B2 (en) * 2013-05-15 2016-10-25 Europesearch S.R.L. Collagen powder, composition and use
US20160114963A1 (en) * 2013-06-03 2016-04-28 Essentra Filter Products Development Co. Pte. Ltd Dispenser, and method of manufacture thereof
RU2016101631A (en) 2013-06-21 2017-07-26 Ферросан Медикал Дивайсиз А/С Extended vacuum dry composition and a syringe to save it
US20150080815A1 (en) * 2013-09-19 2015-03-19 Medline Industries, Inc. Wound dressing containing polysaccharide and collagen
US10111980B2 (en) 2013-12-11 2018-10-30 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
KR101864465B1 (en) * 2014-01-21 2018-06-04 재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소 Micro particles administered in vivo through an endoscopic catheter
US10183132B2 (en) 2014-09-11 2019-01-22 Ethicon Llc Methods and devices for co-delivery of liquid and powdered hemostats and sealants
US20160375202A1 (en) 2015-06-24 2016-12-29 Ethicon, Inc. Hemostatic Powder Delivery Devices and Methods
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods
CN105126152B (en) * 2015-10-07 2018-01-16 中国海洋大学 A gelatin chitosan hemostatic powder
BR112018009313A2 (en) 2015-11-08 2018-11-06 Ethicon Inc hemostatic composition
CN105597144A (en) * 2015-12-31 2016-05-25 北京湃生生物科技有限公司 Absorbable collagen styptic powder and preparing method thereof
CN106178204A (en) * 2016-07-11 2016-12-07 璧靛涧 Catheter for spraying powder hemostatic drug enteroscope

Family Cites Families (183)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2465357A (en) * 1944-08-14 1949-03-29 Upjohn Co Therapeutic sponge and method of making
US2465860A (en) * 1945-10-13 1949-03-29 Standard Manifold Company Inc Carbon holder
GB648619A (en) 1947-03-19 1951-01-10 Ferrosan As Process of producing sponges of gelatine and the like proteins
CH264752A (en) * 1947-06-03 1949-10-31 Hoffmann La Roche A process for producing carriers for drugs.
GB697603A (en) 1948-10-06 1953-09-23 Sydney Arthur Gladstone Improvements in or relating to method of and devices for obtaining tissue from a tumour carried by a patient
US3224434A (en) 1962-11-06 1965-12-21 Waldemar Medical Res Foundatio Cell collector
US3869539A (en) * 1966-12-01 1975-03-04 Ferrosan As Preparations containing fat-soluble vitamins in dry, particulate, free-flowing form dispersible in cold water and method of producing such preparations
US3678933A (en) * 1970-07-17 1972-07-25 Moore Perk Corp Surgical sponge or bandage
FR2167197B1 (en) * 1972-01-10 1974-06-21 Pont Brule Sa improved compositions containing gelatin
US3815580A (en) * 1972-08-31 1974-06-11 C Oster Apparatus for and method of collecting and preserving cytologic samples
US4280954A (en) * 1975-07-15 1981-07-28 Massachusetts Institute Of Technology Crosslinked collagen-mucopolysaccharide composite materials
US4098728A (en) * 1976-01-02 1978-07-04 Solomon Rosenblatt Medical surgical sponge and method of making same
GB1584080A (en) * 1977-12-05 1981-02-04 Ethicon Inc Absorbable hemostatic composition
US4265233A (en) * 1978-04-12 1981-05-05 Unitika Ltd. Material for wound healing
DE2943520C2 (en) * 1979-10-27 1982-05-19 Fa. Carl Freudenberg, 6940 Weinheim, De
DE3146841A1 (en) 1981-11-26 1983-06-01 Beiersdorf Ag Wound-treatment compositions
JPS6318469B2 (en) 1982-08-09 1988-04-19 Koken Kk
US4492305A (en) * 1983-07-08 1985-01-08 Marion Laboratories, Inc. Package for collecting cultures
US4515637A (en) * 1983-11-16 1985-05-07 Seton Company Collagen-thrombin compositions
US4522302A (en) * 1984-03-05 1985-06-11 Sterling Drug Inc. Pre-sterilized medical procedure kit packages
ZA8501661B (en) 1984-03-29 1986-10-29 Minnesota Mining & Mfg Sorbent sheet material
JPS6144825A (en) * 1984-08-09 1986-03-04 Unitika Ltd Hemostatic agent
JPH0430927B2 (en) * 1984-11-19 1992-05-25
JPS61209590A (en) * 1985-03-13 1986-09-17 Asama Kasei Kk Novel immobilized cell and method for fermentative production utilizing same
US4997753A (en) * 1985-04-04 1991-03-05 Verax Corporation Weighted collagen microsponge for immobilizing bioactive material
US4861714A (en) * 1985-04-04 1989-08-29 Verax Corporation Weighted collagen microsponge for immobilizing bioactive material
US4863856A (en) 1985-04-04 1989-09-05 Verax Corporation Weighted collagen microsponge for immobilizing bioactive materials
AT382783B (en) * 1985-06-20 1987-04-10 Immuno Ag A device for applying a tissue adhesive
US5112750A (en) * 1985-06-25 1992-05-12 Asama Chemical Co., Ltd. Immobilized cells and culture method utilizing the same
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
US4696812A (en) 1985-10-28 1987-09-29 Warner-Lambert Company Thrombin preparations
US20020192271A1 (en) 1985-11-26 2002-12-19 Hedner Ulla Karin Elisabeth Method for causing local hemostasis and hemostatic composition for local hemostasis
US5180583A (en) * 1985-11-26 1993-01-19 Hedner Ulla K E Method for the treatment of bleeding disorders
US5690954A (en) 1987-05-22 1997-11-25 Danbiosyst Uk Limited Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
JPH0236261B2 (en) 1987-09-28 1990-08-16 Terumo Corp
JPH01130519A (en) * 1987-11-16 1989-05-23 Mitsubishi Electric Corp Mocvd crystal growing apparatus
IT1219587B (en) 1988-05-13 1990-05-18 Fidia Farmaceutici Polysaccharides carbossiilici autocross
US5024841A (en) * 1988-06-30 1991-06-18 Collagen Corporation Collagen wound healing matrices and process for their production
EP0365705A1 (en) 1988-10-26 1990-05-02 Zentralna Problemna Laboratoria Po Kryobiologia I Lyophilisazia Biopreparation for the treatment of wounds
US4891359A (en) * 1988-12-08 1990-01-02 Johnson & Johnson Patient Care, Inc. Hemostatic collagen paste composition
US5356883A (en) 1989-08-01 1994-10-18 Research Foundation Of State University Of N.Y. Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
US5196185A (en) * 1989-09-11 1993-03-23 Micro-Collagen Pharmaceutics, Ltd. Collagen-based wound dressing and method for applying same
US4982769A (en) * 1990-02-21 1991-01-08 Survival Technology, Inc. Package
JPH0813750B2 (en) 1990-03-01 1996-02-14 持田製薬株式会社 Oral thrombin preparations
US5595735A (en) * 1990-05-23 1997-01-21 Johnson & Johnson Medical, Inc. Hemostatic thrombin paste composition
EP0478827B1 (en) 1990-10-04 1994-04-06 Kallies Import-Export Vertrieb Gmbh Stabilized thrombine, its preparation and its use as a clotting-time agent
US5749895A (en) * 1991-02-13 1998-05-12 Fusion Medical Technologies, Inc. Method for bonding or fusion of biological tissue and material
WO1992014513A1 (en) 1991-02-13 1992-09-03 Interface Biomedical Laboratories Corp. Filler material for use in tissue welding
US5690675A (en) 1991-02-13 1997-11-25 Fusion Medical Technologies, Inc. Methods for sealing of staples and other fasteners in tissue
US5931165A (en) 1994-09-06 1999-08-03 Fusion Medical Technologies, Inc. Films having improved characteristics and methods for their preparation and use
US5669934A (en) 1991-02-13 1997-09-23 Fusion Medical Technologies, Inc. Methods for joining tissue by applying radiofrequency energy to performed collagen films and sheets
WO1992014447A1 (en) * 1991-02-14 1992-09-03 Baxter International Inc. Binding of recognizing substances to liposomes
DE4119140C2 (en) 1991-06-11 1994-05-11 Merz & Co Gmbh & Co Porous, soluble in body fluids and secretions, spongoider molded body, its production and use
FR2679772B1 (en) 1991-08-02 1995-05-19 Peters Sa Emboli particles nonabsorbable COATED hemostatic material.
IT1251151B (en) * 1991-08-05 1995-05-04 Fidia Spa spongy material consisting essentially of hyaluronic acid, or its derivatives
US6620436B1 (en) 1991-10-09 2003-09-16 Lectec Corporation Mixing and dispensing package for a wound dressing
GB9206509D0 (en) 1992-03-25 1992-05-06 Jevco Ltd Heteromorphic sponges containing active agents
GB2266239B (en) 1992-03-25 1996-03-06 Jevco Ltd Wound healing compositions containing chondroitin sulphate oligosaccharides
IL105529D0 (en) * 1992-05-01 1993-08-18 Amgen Inc Collagen-containing sponges as drug delivery for proteins
US5547376A (en) * 1992-06-18 1996-08-20 Harrel; Stephen K. Methods and apparatus for containing and recovering abrasive powders from an abrasive polisher
US5443481A (en) * 1992-07-27 1995-08-22 Lee; Benjamin I. Methods and device for percutaneous sealing of arterial puncture sites
WO1994006460A1 (en) 1992-09-21 1994-03-31 Vitaphore Corporation Embolization plugs for blood vessels
US5334216A (en) 1992-12-10 1994-08-02 Howmedica Inc. Hemostatic plug
AT209887T (en) * 1993-04-02 2001-12-15 Anticancer Inc Methods for administration of compositions beneficial to the hair follicles
AU6705894A (en) * 1993-04-20 1994-11-08 Medchem Products, Inc. Apparatus and method for applying a particulate hemostatic agent to living tissue
US5723308A (en) * 1993-05-14 1998-03-03 Minnesota Mining And Manufacturing Company Culture medium for rapid count of coliform bacteria
US5951583A (en) 1993-05-25 1999-09-14 Vascular Solutions, Inc. Thrombin and collagen procoagulant and process for making the same
US5387208A (en) * 1993-07-26 1995-02-07 The Procter & Gamble Co. Absorbent core having improved dry/wet integrity
US5798091A (en) 1993-07-30 1998-08-25 Alliance Pharmaceutical Corp. Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
US5394886A (en) * 1993-09-20 1995-03-07 Nabai; Hossein Skin biopsy plug and method
AT273035T (en) * 1993-11-03 2004-08-15 Clarion Pharmaceuticals Inc hemostatic plaster
EP0691400B1 (en) * 1993-12-30 2002-03-06 Nitta Gelatin Inc. Process for embedding culture of animal cells
DE4407875C2 (en) 1994-03-04 1996-04-04 Ankerpharm Gmbh Ankerwerk Rudo Medical sponge made of bioabsorbable materials, methods and apparatus for the production thereof
ITPD940054A1 (en) * 1994-03-23 1995-09-25 Fidia Advanced Biopolymers Srl sulfated polysaccharides
CA2146090C (en) 1994-05-10 1998-11-24 Mark E. Mitchell Apparatus and method of mixing materials in a sterile environment
US5462860A (en) 1994-06-06 1995-10-31 Minnesota Mining And Manufacturing Company Conditioned culture medium for rapid growth and detection of microbes
JP2858087B2 (en) 1994-09-19 1999-02-17 グンゼ株式会社 Substrate and tissue culture methods for tissue culture
FR2726571B1 (en) 1994-11-03 1997-08-08 Izoret Georges biological adhesive, process for the preparation and application device for biological adhesive, and curing agents for biological glue
US5660854A (en) 1994-11-28 1997-08-26 Haynes; Duncan H Drug releasing surgical implant or dressing material
AR013829A1 (en) 1996-07-12 2001-01-31 Baxter Int A medical device for delivering volumetric amounts of a first and a second fluid, biochemically reactive and method for suministrarfibrina a surface with said device
AT244584T (en) * 1995-01-16 2003-07-15 Baxter Int Self-supporting sheet-cross-linked fibrin to inhibition of postoperative adhesions
DE19513666C1 (en) 1995-04-11 1996-11-28 Behringwerke Ag Apparatus for bringing together a first liquid and a second solid or liquid component by means of reduced pressure under sterile conditions
JP3799626B2 (en) 1995-04-25 2006-07-19 有限会社ナイセム Cardiovascular repair material and manufacturing method thereof
DE19521324C1 (en) * 1995-06-12 1996-10-31 Immuno Ag Tissue adhesive and using the same as a hemostatic agent
AU7398196A (en) * 1995-10-11 1997-04-30 Fusion Medical Technologies, Inc. Device and method for sealing tissue
CZ318998A3 (en) 1996-04-04 1999-09-15 Baxter Aktiengesellschaft Haemostatic sponge based on collagen, process of its preparation, cover on a frame and kit for preparing such cover
US5948427A (en) * 1996-04-25 1999-09-07 Point Medical Corporation Microparticulate surgical adhesive
US5791352A (en) * 1996-06-19 1998-08-11 Fusion Medical Technologies, Inc. Methods and compositions for inhibiting tissue adhesion
US6066325A (en) * 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US6063061A (en) * 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US7320962B2 (en) 1996-08-27 2008-01-22 Baxter International Inc. Hemoactive compositions and methods for their manufacture and use
CA2211629A1 (en) * 1996-09-17 1998-03-17 Bernard Sams Vial connector assembly for a medicament container
US5795330A (en) 1996-10-10 1998-08-18 Etex Corporation Mixing device
US5743412A (en) * 1996-11-13 1998-04-28 Chrysler Corporation Modular parts supply rack
US5782860A (en) * 1997-02-11 1998-07-21 Biointerventional Corporation Closure device for percutaneous occlusion of puncture sites and tracts in the human body and method
US6045570A (en) * 1997-02-11 2000-04-04 Biointerventional Corporation Biological sealant mixture and system for use in percutaneous occlusion of puncture sites and tracts in the human body and method
US5905029A (en) * 1997-02-19 1999-05-18 Fritz Berthold Method for rapid hygiene testing
FR2759980A1 (en) 1997-02-25 1998-08-28 Bras Michel Container for mixable food ingredients
US5939259A (en) 1997-04-09 1999-08-17 Schleicher & Schuell, Inc. Methods and devices for collecting and storing clinical samples for genetic analysis
EP1059957B1 (en) 1998-03-06 2007-08-29 Baxter International Inc. Turbulence mixing head for a tissue sealant applicator and spray head for same
US6716435B1 (en) * 1997-04-18 2004-04-06 Ganeden Biotech, Inc. Absorbent product containing absorbent structure and Bacillus coagulans
US20020039594A1 (en) * 1997-05-13 2002-04-04 Evan C. Unger Solid porous matrices and methods of making and using the same
US5908054A (en) * 1997-06-16 1999-06-01 Fusion Medical Technologies, Inc. Fluid dispersion and delivery assembly and method
US5957166A (en) 1997-06-16 1999-09-28 Fusion Medical Technologies, Inc. Method and apparatus for dispersing fluid into a material
EP0993311B1 (en) 1997-06-18 2012-11-14 Angiotech Pharmaceuticals (US), Inc. Compositions containing thrombin and microfibrillar collagen, and methods for preparation and use thereof
US6042262A (en) * 1997-07-29 2000-03-28 Stryker Technologies Corportion Apparatus for storing, mixing, and dispensing two-component bone cement
US6162241A (en) 1997-08-06 2000-12-19 Focal, Inc. Hemostatic tissue sealants
CA2301018C (en) 1997-08-22 2006-06-20 Denki Kagaku Kogyo Kabushiki Kaisha Hyaluronic acid gel, method of its production and medical material containing it
US6168788B1 (en) * 1997-09-26 2001-01-02 Leon Wortham Fibrin glue without fibrinogen and biosealant compositions and methods
GB2329840C (en) * 1997-10-03 2007-10-05 Johnson & Johnson Medical Biopolymer sponge tubes
US6303323B1 (en) 1997-10-21 2001-10-16 Cancer Research Campaign Technology Limited Detection of dysplastic or neoplastic cells using anti-MCM5 antibodies
JP3483753B2 (en) 1997-12-29 2004-01-06 タキロン株式会社 Biodegradable and bioabsorbable thermoplastic adhesive material
US6099952A (en) 1998-02-18 2000-08-08 Xomed Surgical Products, Inc. Medical sponge having mucopolysaccharide coating
US20020025921A1 (en) * 1999-07-26 2002-02-28 Petito George D. Composition and method for growing, protecting, and healing tissues and cells
US20020061842A1 (en) * 1998-04-10 2002-05-23 Octapharma Ag Method for sterilizing a native collagen in liquid medium, sterile native collagen obtained, compositions containing it and uses
US6200328B1 (en) 1998-05-01 2001-03-13 Sub Q, Incorporated Device and method for facilitating hemostasis of a biopsy tract
ITPD980169A1 (en) 1998-07-06 2000-01-07 Fidia Advanced Biopolymers Srl Amides of hyaluronic acid and its derivatives and process for their preparation.
US6613070B2 (en) * 1998-08-04 2003-09-02 Baxter International Inc. System and method for sealing vascular penetrations with hemostatic gels
US6334865B1 (en) * 1998-08-04 2002-01-01 Fusion Medical Technologies, Inc. Percutaneous tissue track closure assembly and method
WO2000007505A1 (en) * 1998-08-04 2000-02-17 Fusion Medical Technologies, Inc. Percutaneous tissue track closure assembly and method
US20020015724A1 (en) * 1998-08-10 2002-02-07 Chunlin Yang Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing
US20020019062A1 (en) * 1999-06-18 2002-02-14 Peter Lea Assay devices
US6454787B1 (en) 1998-12-11 2002-09-24 C. R. Bard, Inc. Collagen hemostatic foam
US6283933B1 (en) 1998-12-23 2001-09-04 Closure Medical Corporation Applicator for dispensable liquids
AT222781T (en) 1998-12-23 2002-09-15 Aventis Behring Gmbh Fibrin adhesive and process for its manufacture
US6977231B1 (en) 1999-01-21 2005-12-20 Nipro Corporation Suturable adhesion-preventing membrane
US6862470B2 (en) 1999-02-02 2005-03-01 Senorx, Inc. Cavity-filling biopsy site markers
CN1288197C (en) 1999-02-19 2006-12-06 电气化学工业株式会社 Hyaluronic acid gel composition, process for producing the same, and medical material containing the same
US6312725B1 (en) 1999-04-16 2001-11-06 Cohesion Technologies, Inc. Rapid gelling biocompatible polymer composition
EP1053758A1 (en) 1999-05-19 2000-11-22 Resorba Chirurgisches Nahtmaterial Franz Hiltner GmbH & Co. Bioabsorbable implant
US6706690B2 (en) * 1999-06-10 2004-03-16 Baxter Healthcare Corporation Hemoactive compositions and methods for their manufacture and use
WO2001016210A1 (en) 1999-08-27 2001-03-08 Cohesion Technologies, Inc. Compositions that form interpenetrating polymer networks for use as high strength medical sealants
US20030095993A1 (en) * 2000-01-28 2003-05-22 Hanne Bentz Gel-infused sponges for tissue repair and augmentation
IT1317832B1 (en) * 2000-02-15 2003-07-15 Eurores S R L Process for micronized collagen preparation and therapeutic sueapplicazioni.
WO2001060424A2 (en) 2000-02-18 2001-08-23 Regeneration Technologies, Inc. Implantable tissues infused with growth factors and other additives
EP1149906A1 (en) 2000-04-25 2001-10-31 Pliva, Farmaceutska, Industrija, Dionicko Drustvo Thrombopoietin receptor modulating peptide
AU5571601A (en) * 2000-04-28 2001-11-12 Fziomed Inc Hemostatic compositions of polyacids and polyalkylene oxides and methods for their use
AT412445B (en) * 2000-06-20 2005-03-25 Biering Wolfgang Liquid collagen-hemostat
CA2415713A1 (en) * 2000-07-13 2002-01-24 Invitrogen Corporation Methods and compositions for rapid protein and peptide extraction and isolation using a lysis matrix
US20030032143A1 (en) * 2000-07-24 2003-02-13 Neff Thomas B. Collagen type I and type III compositions for use as an adhesive and sealant
WO2002009792A1 (en) * 2000-07-28 2002-02-07 Anika Therapeutics, Inc. Bioabsorbable composites of derivatized hyaluronic acid
US6890342B2 (en) * 2000-08-02 2005-05-10 Loma Linda University Method and apparatus for closing vascular puncture using hemostatic material
JP2002060341A (en) * 2000-08-21 2002-02-26 Terumo Corp Hemostatic agent
IT1317358B1 (en) 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl cross-linked hyaluronic acid derivatives.
US6364519B1 (en) * 2000-09-26 2002-04-02 Smith & Nephew, Inc. Bone cement system
US6458380B1 (en) 2000-11-09 2002-10-01 Richard Leaderman Dressing and preparation delivery system
US6635272B2 (en) 2000-11-09 2003-10-21 Richard N. Leaderman Wound dressing and drug delivery system
US20030009194A1 (en) * 2000-12-07 2003-01-09 Saker Mark B. Tissue tract sealing device
US7041868B2 (en) 2000-12-29 2006-05-09 Kimberly-Clark Worldwide, Inc. Bioabsorbable wound dressing
US20020164322A1 (en) 2001-01-25 2002-11-07 Alfred Schaufler Suspension comprising fibrinogen, thrombin and alcohol, a method for preparing such a suspension, a method for coating a carrier with such a suspension, a method of drying a coating of a carrier, and a coated collagen sponge
US7052713B2 (en) * 2001-02-13 2006-05-30 Nycomed Pharma As Carrier with solid fibrinogen and solid thrombin
US6733774B2 (en) * 2001-01-25 2004-05-11 Nycomed Pharma As Carrier with solid fibrinogen and solid thrombin
US8187625B2 (en) * 2001-03-12 2012-05-29 Boston Scientific Scimed, Inc. Cross-linked gelatin composition comprising a wetting agent
US6685745B2 (en) 2001-05-15 2004-02-03 Scimed Life Systems, Inc. Delivering an agent to a patient's body
BR0102637A (en) * 2001-05-17 2003-02-25 Johnson & Johnson Ind Com adhesive bandage
US7371403B2 (en) 2002-06-14 2008-05-13 Providence Health System-Oregon Wound dressing and method for controlling severe, life-threatening bleeding
US7435425B2 (en) * 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US20060189516A1 (en) 2002-02-19 2006-08-24 Industrial Technology Research Institute Method for producing cross-linked hyaluronic acid-protein bio-composites
JP4668510B2 (en) * 2001-09-29 2011-04-13 持田製薬株式会社 Flexible containers topical hemostatic pharmaceutical composition
AU2002367086B2 (en) * 2001-12-21 2008-08-21 Ferrosan Medical Devices A/S A hemostatic kit, a method of preparing a hemostatic agent and a method of promoting hemostasis
US7923431B2 (en) 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
CN1635853B (en) * 2002-02-20 2010-05-12 21世纪国际新技术株式会社 Fine powder drug administration apparatus
DE60323943D1 (en) 2002-02-21 2008-11-20 Encelle Inc Immobilized bioactive hydrogel matrices for surface coatings
WO2005000265A2 (en) * 2002-09-11 2005-01-06 Elan Pharma International Ltd. Gel-stabilized nanoparticulate active agent compositions
GB2393120A (en) 2002-09-18 2004-03-24 Johnson & Johnson Medical Ltd Compositions for wound treatment
US20040079763A1 (en) * 2002-10-29 2004-04-29 Powell Cindy Hagood Duplex storage pouch
US20040101546A1 (en) * 2002-11-26 2004-05-27 Gorman Anne Jessica Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents
US20040120993A1 (en) * 2002-12-20 2004-06-24 Guanghui Zhang Hemostatic wound dressing and fabric and methods of making and using same
US7112713B2 (en) 2003-03-12 2006-09-26 Gelsus Research And Consulting, Inc. Dressing based on the Teorell-Meyer gradient
US7129210B2 (en) * 2003-07-23 2006-10-31 Covalent Medical, Inc. Tissue adhesive sealant
US20050137512A1 (en) * 2003-12-23 2005-06-23 Campbell Todd D. Wound dressing and method for controlling severe, life-threatening bleeding
US7109163B2 (en) 2004-01-30 2006-09-19 Ethicon, Inc. Hemostatic compositions and devices
US20050218541A1 (en) 2004-04-02 2005-10-06 Peng Henry T Method of producing interpenetrating polymer network
US20050245905A1 (en) 2004-04-30 2005-11-03 Schmidt Steven P Local drug-delivery system
GB2414021A (en) 2004-05-10 2005-11-16 Johnson & Johnson Medical Ltd Absorbable haemostatic materials
US7968085B2 (en) * 2004-07-05 2011-06-28 Ascendis Pharma A/S Hydrogel formulations
KR20070046093A (en) * 2004-07-09 2007-05-02 훼로산 아크티에 셀스카브 Haemostatic composition comprising hyaluronic acid
EA016776B9 (en) * 2004-09-30 2012-11-30 Ковалон Текнолоджиз Инк. Non-adhesive elastic gelatin matrices
US9114194B2 (en) 2006-05-12 2015-08-25 W. L. Gore & Associates, Inc. Immobilized biologically active entities having high biological activity following mechanical manipulation
US8496953B2 (en) 2006-05-12 2013-07-30 W. L. Gore & Associates, Inc. Immobilized biologically active entities having a high degree of biological activity following sterilization
US20080095830A1 (en) * 2006-10-20 2008-04-24 Van Holten Robert W Method for making a dressing
US20080311172A1 (en) 2007-04-25 2008-12-18 Schapira Jay N Programmed-release, nanostructured biological construct
US20090087569A1 (en) * 2007-09-27 2009-04-02 Fenchem Enterprises Ltd. Methods for Preparing Highly Stable Hyaluronic Acid

Also Published As

Publication number Publication date
WO2005072700A3 (en) 2005-09-09
CA2554994A1 (en) 2005-08-11
RU2377022C9 (en) 2010-08-10
EP1713521A2 (en) 2006-10-25
US20070160543A1 (en) 2007-07-12
EP1713521B1 (en) 2010-07-28
WO2005072700A2 (en) 2005-08-11
AR054637A1 (en) 2007-07-11
CN1921896A (en) 2007-02-28
DE602005022554D1 (en) 2010-09-09
CA2554994C (en) 2015-05-19
US7923031B2 (en) 2011-04-12
JP2007519450A (en) 2007-07-19
CN1921896B (en) 2010-11-24
RU2377022C2 (en) 2009-12-27
RU2006131128A (en) 2008-03-10

Similar Documents

Publication Publication Date Title
DE602005012267D1 (en) N of devices
AT440908T (en) Heterogeneous polymer blends and from formkírper
AT552301T (en) Propylene resin composition and use thereof
DE60331343D1 (en) Compositions and methods for altering the tocotrienolgehalts
DE602004017832D1 (en) Display component setting and display component-
DE60317699D1 (en) Fermentation processes and compositions
DE60302634D1 (en) Bipolar and isolation
DE602005009327D1 (en) Dihydrotetrabenazine and pharmaceutical compositions containing them
AT541470T (en) Physiological cooling compositions
DE602005009140D1 (en) MQ and t-propylsiloxanharzzusammensetzungen
DE60320458D1 (en) Release compositions and articles made therefrom
DE602004022316D1 (en) Alloy compositions and devices containing them
AT517992T (en) Functional and Hyperfunctional sirna
DE60306687D1 (en) Multi-purpose polymers procedures, and compositions
AT382075T (en) Polytrimethylenetherdiolhaltige coating compositions
DE602005019947D1 (en) Surgical fastener
DE602006020652D1 (en) Public- and private network service -Verwaltungsysteme and procedures
DE602006002367D1 (en) Ity and continuity
AT538805T (en) Fgf-variants and application procedures for
AT509533T (en) compositions Canolaproteinisolat
AT521958T (en) Display and operational procedures for
AT520757T (en) Polycationic viscoelastic compositions
DE602004005753D1 (en) Combinations of resin compositions and methods for use
DE602004031974D1 (en) hemostasis valve
AT455712T (en) Donors and process

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties